Phase I dose-escalation oncology trials with sequential multiple schedules.

Burak Kürsad GünhanSebastian WeberAbdelkader SeroutouTim Friede

Published in: BMC medical research methodology (2021)

In phase I oncology trials with sequential multiple schedules, the use of all relevant information is of great importance. For these trials, the adapted TITE-PK which combines information using PK principles is recommended.

Keyphrases

palliative care
health information
healthcare
open label
clinical trial
social media